©The Author(s) 2022.
World J Clin Cases. Sep 26, 2022; 10(27): 9556-9572
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9556
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9556
Table 3 Mechanisms of arrhythmogenicity[55]
| Mechanisms of arrhythmogenicity |
| QT prolonging drugs (anti-coronavirus disease 2019 pharmacotherapies/antibiotic-associated diarrheas/other agents) |
| Drug-drug interactions |
| Previous heart rhythm conditions (long QT and Brugada syndrome) |
| Acute myocardial injury/myocarditis |
| Hypoxia |
| Systemic inflammation |
| Autonomic dysfunction (sympathetic/parasympathetic) |
| Electrolyte abnormalities |
| Cardiovascular comorbidities (hypertension, coronary artery disease, and cardiomyopathy) |
- Citation: Vidal-Perez R, Brandão M, Pazdernik M, Kresoja KP, Carpenito M, Maeda S, Casado-Arroyo R, Muscoli S, Pöss J, Fontes-Carvalho R, Vazquez-Rodriguez JM. Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic. World J Clin Cases 2022; 10(27): 9556-9572
- URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9556.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i27.9556